166 related articles for article (PubMed ID: 7979365)
1. Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II.
Tomkinson B; Grehn L; Fransson B; Zetterqvist O
Arch Biochem Biophys; 1994 Nov; 314(2):276-9. PubMed ID: 7979365
[TBL] [Abstract][Full Text] [Related]
2. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
3. Purification, substrate specificity, and classification of tripeptidyl peptidase II.
Bålöw RM; Tomkinson B; Ragnarsson U; Zetterqvist O
J Biol Chem; 1986 Feb; 261(5):2409-17. PubMed ID: 3511062
[TBL] [Abstract][Full Text] [Related]
4. Tripeptidyl-peptidase II: a multi-purpose peptidase.
Tomkinson B; Lindås AC
Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
[TBL] [Abstract][Full Text] [Related]
5. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
[TBL] [Abstract][Full Text] [Related]
6. Rat tripeptidyl peptidase I: molecular cloning, functional expression, tissue localization and enzymatic characterization.
Du PG; Kato S; Li YH; Maeda T; Yamane T; Yamamoto S; Fujiwara M; Yamamoto Y; Nishi K; Ohkubo I
Biol Chem; 2001 Dec; 382(12):1715-25. PubMed ID: 11843185
[TBL] [Abstract][Full Text] [Related]
7. Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type.
Tomkinson B; Wernstedt C; Hellman U; Zetterqvist O
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7508-12. PubMed ID: 3313395
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Leblond B; Moore AN; Zhao L; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2005 Nov; 48(23):7333-42. PubMed ID: 16279793
[TBL] [Abstract][Full Text] [Related]
9. Human and rat dipeptidyl peptidase III: biochemical and mass spectrometric arguments for similarities and differences.
Abramić M; Schleuder D; Dolovcak L; Schröder W; Strupat K; Sagi D; Peter-Katalini J; Vitale L
Biol Chem; 2000 Dec; 381(12):1233-43. PubMed ID: 11209758
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Law JK; Marabout B; Luthra PM; Moore AN; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2000 Feb; 43(4):664-74. PubMed ID: 10691692
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
De Winter H; Breslin H; Miskowski T; Kavash R; Somers M
J Mol Graph Model; 2005 Apr; 23(5):409-18. PubMed ID: 15781183
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase III from rat liver cytosol: purification, molecular cloning and immunohistochemical localization.
Ohkubo I; Li YH; Maeda T; Yamamoto Y; Yamane T; Du PG; Nishi K
Biol Chem; 1999 Dec; 380(12):1421-30. PubMed ID: 10661869
[TBL] [Abstract][Full Text] [Related]
14. Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins.
Barsun M; Jajcanin N; Vukelić B; Spoljarić J; Abramić M
Biol Chem; 2007 Mar; 388(3):343-8. PubMed ID: 17338643
[TBL] [Abstract][Full Text] [Related]
15. Association and dissociation of the tripeptidyl-peptidase II complex as a way of regulating the enzyme activity.
Tomkinson B
Arch Biochem Biophys; 2000 Apr; 376(2):275-80. PubMed ID: 10775413
[TBL] [Abstract][Full Text] [Related]
16. Axonal transports of tripeptidyl peptidase II in rat sciatic nerves.
Chikuma T; Shimizu M; Tsuchiya Y; Kato T; Hojo H
Neurochem Int; 2007 Jan; 50(1):236-42. PubMed ID: 17023090
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the endopeptidase activity of tripeptidyl-peptidase II.
Eklund S; Dogan J; Jemth P; Kalbacher H; Tomkinson B
Biochem Biophys Res Commun; 2012 Aug; 424(3):503-7. PubMed ID: 22771804
[TBL] [Abstract][Full Text] [Related]
18. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
Shibuya-Saruta H; Kasahara Y; Hashimoto Y
J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
[TBL] [Abstract][Full Text] [Related]
19. Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver.
Bålöw RM; Ragnarsson U; Zetterqvist O
J Biol Chem; 1983 Oct; 258(19):11622-8. PubMed ID: 6352701
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequence of cDNA covering the N-terminus of human tripeptidyl peptidase II.
Tomkinson B
Biomed Biochim Acta; 1991; 50(4-6):727-9. PubMed ID: 1840501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
